Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link

Volume 16, Number 8—August 2010

Perspective

Hantavirus Infections in Humans and Animals, China

Yong-Zhen ZhangComments to Author , Yang Zou, Zhen F. Fu, and Alexander Plyusnin
Author affiliations: State Key Laboratory for Infectious Disease Control and Prevention, Beijing, People’s Republic of China (Y.-Z. Zhang, Y. Zou); University of Georgia, Athens, Georgia, USA (Z.F. Fu); University of Helsinki, Helsinki, Finland (A. Plyusnin)

Main Article

Table 3

Inactivated hantavirus vaccines used in China, 1995–2010

Virus Cell culture used Vaccination procedure* Protection, %
Hantaan Mongolian gerbil kidney 3 + 1 >90
Seoul Golden hamster kidney 2 + 1 >95
Hantaan Suckling mouse brain 3 + 1 >90
Hantaan/Seoul Mongolian gerbil kidney 2 + 1 >95
Hantaan/Seoul Vero 2 + 1 >85†

*No. doses + no. boosters.
†Seroconversion rate of human hantavirus antibody determined by plaque-reduction neutralization test.

Main Article

Page created: March 30, 2011
Page updated: March 30, 2011
Page reviewed: March 30, 2011
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external